Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review

Márcio G. Kiuchi, Murray D. Esler, Gregory D. Fink, John W. Osborn, Christopher T. Banek, Michael Böhm, Kate M. Denton, Gerald F. DiBona, Thomas H. Everett, Guido Grassi, Richard E. Katholi, Mark M. Knuepfer, Ulla C. Kopp, David J. Lefer, Thomas E. Lohmeier, Clive N. May, Felix Mahfoud, Julian F.R. Paton, Roland E. Schmieder, Peter R. PellegrinoYehonatan Sharabi, Markus P. Schlaich

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Three recent renal denervation studies in both drug-naïve and drug-treated hypertensive patients demonstrated a significant reduction of ambulatory blood pressure compared with respective sham control groups. Improved trial design, selection of relevant patient cohorts, and optimized interventional procedures have likely contributed to these positive findings. However, substantial variability in the blood pressure response to renal denervation can still be observed and remains a challenging and important problem. The International Sympathetic Nervous System Summit was convened to bring together experts in both experimental and clinical medicine to discuss the current evidence base, novel developments in our understanding of neural interplay, procedural aspects, monitoring of technical success, and others. Identification of relevant trends in the field and initiation of tailored and combined experimental and clinical research efforts will help to address remaining questions and provide much-needed evidence to guide clinical use of renal denervation for hypertension treatment and other potential indications.

Original languageEnglish (US)
Pages (from-to)3006-3017
Number of pages12
JournalJournal of the American College of Cardiology
Volume73
Issue number23
DOIs
StatePublished - Jun 18 2019

Fingerprint

Sympathetic Nervous System
Denervation
Kidney
Blood Pressure
Renal Hypertension
Clinical Medicine
Pharmaceutical Preparations
Patient Selection
Biomedical Research
Control Groups
Research
Therapeutics

Keywords

  • blood pressure
  • cardiovascular disease
  • hypertension
  • renal denervation
  • sympathetic nervous system

Cite this

Renal Denervation Update From the International Sympathetic Nervous System Summit : JACC State-of-the-Art Review. / Kiuchi, Márcio G.; Esler, Murray D.; Fink, Gregory D.; Osborn, John W.; Banek, Christopher T.; Böhm, Michael; Denton, Kate M.; DiBona, Gerald F.; Everett, Thomas H.; Grassi, Guido; Katholi, Richard E.; Knuepfer, Mark M.; Kopp, Ulla C.; Lefer, David J.; Lohmeier, Thomas E.; May, Clive N.; Mahfoud, Felix; Paton, Julian F.R.; Schmieder, Roland E.; Pellegrino, Peter R.; Sharabi, Yehonatan; Schlaich, Markus P.

In: Journal of the American College of Cardiology, Vol. 73, No. 23, 18.06.2019, p. 3006-3017.

Research output: Contribution to journalReview article

Kiuchi, MG, Esler, MD, Fink, GD, Osborn, JW, Banek, CT, Böhm, M, Denton, KM, DiBona, GF, Everett, TH, Grassi, G, Katholi, RE, Knuepfer, MM, Kopp, UC, Lefer, DJ, Lohmeier, TE, May, CN, Mahfoud, F, Paton, JFR, Schmieder, RE, Pellegrino, PR, Sharabi, Y & Schlaich, MP 2019, 'Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review', Journal of the American College of Cardiology, vol. 73, no. 23, pp. 3006-3017. https://doi.org/10.1016/j.jacc.2019.04.015
Kiuchi, Márcio G. ; Esler, Murray D. ; Fink, Gregory D. ; Osborn, John W. ; Banek, Christopher T. ; Böhm, Michael ; Denton, Kate M. ; DiBona, Gerald F. ; Everett, Thomas H. ; Grassi, Guido ; Katholi, Richard E. ; Knuepfer, Mark M. ; Kopp, Ulla C. ; Lefer, David J. ; Lohmeier, Thomas E. ; May, Clive N. ; Mahfoud, Felix ; Paton, Julian F.R. ; Schmieder, Roland E. ; Pellegrino, Peter R. ; Sharabi, Yehonatan ; Schlaich, Markus P. / Renal Denervation Update From the International Sympathetic Nervous System Summit : JACC State-of-the-Art Review. In: Journal of the American College of Cardiology. 2019 ; Vol. 73, No. 23. pp. 3006-3017.
@article{a3d236d8edf840f48e5cd57ea4636f20,
title = "Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review",
abstract = "Three recent renal denervation studies in both drug-na{\"i}ve and drug-treated hypertensive patients demonstrated a significant reduction of ambulatory blood pressure compared with respective sham control groups. Improved trial design, selection of relevant patient cohorts, and optimized interventional procedures have likely contributed to these positive findings. However, substantial variability in the blood pressure response to renal denervation can still be observed and remains a challenging and important problem. The International Sympathetic Nervous System Summit was convened to bring together experts in both experimental and clinical medicine to discuss the current evidence base, novel developments in our understanding of neural interplay, procedural aspects, monitoring of technical success, and others. Identification of relevant trends in the field and initiation of tailored and combined experimental and clinical research efforts will help to address remaining questions and provide much-needed evidence to guide clinical use of renal denervation for hypertension treatment and other potential indications.",
keywords = "blood pressure, cardiovascular disease, hypertension, renal denervation, sympathetic nervous system",
author = "Kiuchi, {M{\'a}rcio G.} and Esler, {Murray D.} and Fink, {Gregory D.} and Osborn, {John W.} and Banek, {Christopher T.} and Michael B{\"o}hm and Denton, {Kate M.} and DiBona, {Gerald F.} and Everett, {Thomas H.} and Guido Grassi and Katholi, {Richard E.} and Knuepfer, {Mark M.} and Kopp, {Ulla C.} and Lefer, {David J.} and Lohmeier, {Thomas E.} and May, {Clive N.} and Felix Mahfoud and Paton, {Julian F.R.} and Schmieder, {Roland E.} and Pellegrino, {Peter R.} and Yehonatan Sharabi and Schlaich, {Markus P.}",
year = "2019",
month = "6",
day = "18",
doi = "10.1016/j.jacc.2019.04.015",
language = "English (US)",
volume = "73",
pages = "3006--3017",
journal = "Journal of the American College of Cardiology.",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "23",

}

TY - JOUR

T1 - Renal Denervation Update From the International Sympathetic Nervous System Summit

T2 - JACC State-of-the-Art Review

AU - Kiuchi, Márcio G.

AU - Esler, Murray D.

AU - Fink, Gregory D.

AU - Osborn, John W.

AU - Banek, Christopher T.

AU - Böhm, Michael

AU - Denton, Kate M.

AU - DiBona, Gerald F.

AU - Everett, Thomas H.

AU - Grassi, Guido

AU - Katholi, Richard E.

AU - Knuepfer, Mark M.

AU - Kopp, Ulla C.

AU - Lefer, David J.

AU - Lohmeier, Thomas E.

AU - May, Clive N.

AU - Mahfoud, Felix

AU - Paton, Julian F.R.

AU - Schmieder, Roland E.

AU - Pellegrino, Peter R.

AU - Sharabi, Yehonatan

AU - Schlaich, Markus P.

PY - 2019/6/18

Y1 - 2019/6/18

N2 - Three recent renal denervation studies in both drug-naïve and drug-treated hypertensive patients demonstrated a significant reduction of ambulatory blood pressure compared with respective sham control groups. Improved trial design, selection of relevant patient cohorts, and optimized interventional procedures have likely contributed to these positive findings. However, substantial variability in the blood pressure response to renal denervation can still be observed and remains a challenging and important problem. The International Sympathetic Nervous System Summit was convened to bring together experts in both experimental and clinical medicine to discuss the current evidence base, novel developments in our understanding of neural interplay, procedural aspects, monitoring of technical success, and others. Identification of relevant trends in the field and initiation of tailored and combined experimental and clinical research efforts will help to address remaining questions and provide much-needed evidence to guide clinical use of renal denervation for hypertension treatment and other potential indications.

AB - Three recent renal denervation studies in both drug-naïve and drug-treated hypertensive patients demonstrated a significant reduction of ambulatory blood pressure compared with respective sham control groups. Improved trial design, selection of relevant patient cohorts, and optimized interventional procedures have likely contributed to these positive findings. However, substantial variability in the blood pressure response to renal denervation can still be observed and remains a challenging and important problem. The International Sympathetic Nervous System Summit was convened to bring together experts in both experimental and clinical medicine to discuss the current evidence base, novel developments in our understanding of neural interplay, procedural aspects, monitoring of technical success, and others. Identification of relevant trends in the field and initiation of tailored and combined experimental and clinical research efforts will help to address remaining questions and provide much-needed evidence to guide clinical use of renal denervation for hypertension treatment and other potential indications.

KW - blood pressure

KW - cardiovascular disease

KW - hypertension

KW - renal denervation

KW - sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=85066481995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066481995&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2019.04.015

DO - 10.1016/j.jacc.2019.04.015

M3 - Review article

C2 - 31196459

AN - SCOPUS:85066481995

VL - 73

SP - 3006

EP - 3017

JO - Journal of the American College of Cardiology.

JF - Journal of the American College of Cardiology.

SN - 0735-1097

IS - 23

ER -